CAS 64315-36-2|Acetaminophen-D4
| Common Name | Acetaminophen-D4 | ||
|---|---|---|---|
| CAS Number | 64315-36-2 | Molecular Weight | 155.18700 |
| Density | / | Boiling Point | / |
| Molecular Formula | C8H5D4NO2 | Melting Point | 169-171°C (dec.) |
| MSDS | ChineseUSA | Flash Point | 9℃ |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | Acetaminophen-D4 |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Melting Point | 169-171°C (dec.) |
|---|---|
| Molecular Formula | C8H5D4NO2 |
| Molecular Weight | 155.18700 |
| Flash Point | 9℃ |
| Exact Mass | 155.08800 |
| PSA | 49.33000 |
| LogP | 1.42360 |
| InChIKey | RZVAJINKPMORJF-QFFDRWTDSA-N |
| SMILES | CC(=O)Nc1ccc(O)cc1 |
| Storage condition | -20°C Freezer |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xn,T,F |
| Risk Phrases | 22-36/37/38-39/23/24/25-23/24/25-11 |
| Safety Phrases | 26-36-45-36/37-16-7 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
Articles5
More Articles| In vitro metabolism and drug-drug interaction potential of UTL-5g, a novel chemo- and radioprotective agent. Drug Metab. Dispos. 42(12) , 2058-67, (2014) N-(2,4-dichlorophenyl)-5-methyl-1,2-oxazole-3-carboxamide (UTL-5g), a potential chemo- and radioprotective agent, acts as a prodrug requiring bioactivation to the active metabolite 5-methylisoxazole-3... | |
| Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds. Drug Metab. Dispos. 44 , 435-44, (2016) In vitro models based on primary human hepatocytes (PHH) have been advanced for clearance (CL) prediction of metabolically stable compounds, representing state-of-the-art assay systems for drug discov... | |
| Cytochrome P450 induction response in tethered spheroids as a three-dimensional human hepatocyte in vitro model. J. Appl. Toxicol. 36 , 320-9, (2016) Cytochrome P450 (CYP) induction is a key risk factor of clinical drug-drug interactions that has to be mitigated in the early phases of drug discovery. Three-dimensional (3D) cultures of hepatocytes i... |
Synonyms
| N-(2,3,5,6-tetradeuterio-4-hydroxyphenyl)acetamide |
